-
Something wrong with this record ?
Neurohumoral changes in chronic heart failure
L. Spinarova, J. Vitovec
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
18345252
DOI
10.5507/bp.2007.035
Knihovny.cz E-resources
- MeSH
- Cytokines physiology MeSH
- Humans MeSH
- Neurosecretory Systems physiopathology MeSH
- Heart Failure physiopathology MeSH
- Vasodilation physiology MeSH
- Vasoconstriction physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND: Humoral systems play an important role in the pathophysiology and development of chronic heart failure (CHF). METHODS: We conducted a search of neurohumoral activation in heart failure and its risk in the development of CHF. RESULTS AND CONCLUSION: Neurohumoral factors may be divided into vasoconstrictive, vasodilative and cytokines. The main vasoconstrictive systems are the renin-angiotensin-aldosterone system (RAAS) and the sympathoadrenal system (SAS). Cytokines include tumour necrosis factor (TNF) alpha and interleukins. The systems of actions are interconnected and they mutually influence their secretion and activities. The possibilities of their detection and assessment for clinical purposes depend on their changes and kinetics in the organism and on the activity of individual metabolites. Apart from their vasoactive effects, the majority of humoral actions also interfere in the process of remodelling, function of the endothelium, blood elements, cardiomyocytes, cells of the smooth muscles, and in immunity as well as inflammatory processes. The rapid development of knowledge on the humoral actions in recent years has made possible their utilisation in diagnostics, treatment and prognosis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003614
- 003
- CZ-PrNML
- 005
- 20130222131149.0
- 007
- ta
- 008
- 130128s2007 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2007.035 $2 doi
- 035 __
- $a (PubMed)18345252
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Špinarová, Lenka, $d 1961- $7 xx0061415 $u 1st Internal Cardioangiologic Department, Medical Faculty of Masaryk University, Brno
- 245 10
- $a Neurohumoral changes in chronic heart failure / $c L. Spinarova, J. Vitovec
- 520 9_
- $a BACKGROUND: Humoral systems play an important role in the pathophysiology and development of chronic heart failure (CHF). METHODS: We conducted a search of neurohumoral activation in heart failure and its risk in the development of CHF. RESULTS AND CONCLUSION: Neurohumoral factors may be divided into vasoconstrictive, vasodilative and cytokines. The main vasoconstrictive systems are the renin-angiotensin-aldosterone system (RAAS) and the sympathoadrenal system (SAS). Cytokines include tumour necrosis factor (TNF) alpha and interleukins. The systems of actions are interconnected and they mutually influence their secretion and activities. The possibilities of their detection and assessment for clinical purposes depend on their changes and kinetics in the organism and on the activity of individual metabolites. Apart from their vasoactive effects, the majority of humoral actions also interfere in the process of remodelling, function of the endothelium, blood elements, cardiomyocytes, cells of the smooth muscles, and in immunity as well as inflammatory processes. The rapid development of knowledge on the humoral actions in recent years has made possible their utilisation in diagnostics, treatment and prognosis.
- 650 _2
- $a cytokiny $x fyziologie $7 D016207
- 650 _2
- $a srdeční selhání $x patofyziologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neurosekreční systémy $x patofyziologie $7 D009490
- 650 _2
- $a vazokonstrikce $x fyziologie $7 D014661
- 650 _2
- $a vazodilatace $x fyziologie $7 D014664
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Vítovec, Jiří, $d 1951- $7 mzk2003183010 $u 1st Internal Cardioangiologic Department, Medical Faculty of Masaryk University, Brno
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 151, č. 2 (2007), s. 201-207
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130222131343 $b ABA008
- 999 __
- $a ok $b bmc $g 966270 $s 801809
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2007 $b 151 $c 2 $d 201-207 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128